Replies to post #506867 on $Stock*Shop*Charts*News*Option$

[Tuff-Stuff]

<>The proposed merger between Valeant Pharmaceuticals (VRX) and Actavis (ACT) is on hold after a disagreement on the terms of the deal derails discussions, sources say. Should the deal eventually come to fruition, the combined market value of the two firms would be ~$35B.